Reducing attrition and maximizing ADC impact in metastatic breast cancer
touchIN CONVERSATION for touchONCOLOGY
Identifying patients at risk of treatment attrition is an important part of treatment decision-making, as these patients may miss opportunities to receive subsequent treatments that could improve survival and quality of life. Listen to breast cancer experts consider the impact of treatment attrition in metastatic breast cancer and review evidence supporting the earlier integration of antibody–drug conjugates in the treatment pathway.
The experts
Prof. Fatima Cardoso, Centre Antoine Lacassagne and Advanced Breast Cance (ABC) Global Alliance, Nice, France…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.